A comparison of interferon-γ and IP-10 for the diagnosis of tuberculosis

Pediatrics

Volumn 134, Issue 6, 2014, Pages e1568-e1575

  Holm, Line Lindebo ^a   Rose, Michala Vaaben ^a   Kimaro, Godfather ^b   Bygbjerg, Ib C ^c   Mfinanga, Sayoki G ^b   Ravn, Pernille ^a,d   Ruhwald, Morten ^e  

^a HVIDOVRE HOSPITAL   (Denmark)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d HILLERØD HOSPITAL   (Denmark)

^e STATENS SERUM INSTITUT   (Denmark)

Author keywords

Children; Diagnosis; Interferon release assay; IP 10; Tuberculosis

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; CXCL10 PROTEIN, HUMAN;

ADULT; ARTICLE; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; IMMUNOASSAY; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; IP 10 TEST; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS TEST KIT; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SCHOOL CHILD; SPUTUM CYTODIAGNOSIS; TANZANIAN; TUBERCULOSIS; BLOOD; COMPARATIVE STUDY; DEVELOPING COUNTRY; HIV INFECTIONS; INFANT; OPPORTUNISTIC INFECTIONS; PREDICTIVE VALUE; TANZANIA;

CHEMOKINE CXCL10; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; MALE; OPPORTUNISTIC INFECTIONS; PREDICTIVE VALUE OF TESTS; TANZANIA; TUBERCULOSIS;

EID: 84913534469     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-1570     Document Type: Article

References (38)

1. WHO, Childhood Tuberculosis. Available at: www.who.int/tb/challenges/children/en/index.html. Accessed January 27, 2012
2. McNally LM, Jeena PM, Gajee K, et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet. 2007;369(9571):1440-1451
3. Zar HJ, Connell TG, Nicol M. Diagnosis of pulmonary tuberculosis in children: new advances. Expert Rev Anti Infect Ther. 2010;8(3):277-288
4. Cuevas LE, Browning R, Bossuyt P, et al. Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel. J Infect Dis. 2012;205(suppl 2):S209-S215
5. Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/rr5905a1.htm. Accessed May 8, 2012
6. Haustein T, Ridout DA, Hartley JC, et al. The likelihood of an indeterminate test result from a whole-blood interferon-γ release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J. 2009;28(8):669-673
7. Connell TG, Tebruegge M, Ritz N, Bryant PA, Leslie D, Curtis N. Indeterminate interferon-γ release assay results in children. Pediatr Infect Dis J. 2010;29(3):285-286
8. Dayal R, Verma V, Sharma B, et al. Diagnostic value of interferon-gamma release assays (QuantiFERON-TB Gold® In Tube) in childhood tuberculosis. Indian J Pediatr. 2012;79(2):183-187
9. Sester M, Sotgiu G, Lange C, et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2011;37(1):100-111
10. Ruhwald M, Aabye MG, Ravn P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn. 2012;12(2):175-187
11. Chegou NN, Detjen AK, Thiart L, et al. Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting. PLoS One. 2013;8(5):e64226
12. Chegou NN, Heyckendorf J, Walzl G, Lange C, Ruhwald M. Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis. Eur Respir J. 2013;43(5):1472-1486
13. Goletti D, Raja A, Ahamed Kabeer BS, et al. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J Infect. 2010; 61(2):133-143
14. Kabeer BS, Raja A, Raman B, et al. IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy. BMC Infect Dis. 2011;11:135
15. Lighter J, Rigaud M, Huie M, Peng CH, Pollack H. Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. Int J Tuberc Lung Dis. 2009;13(6):731-736
16. Alsleben N, Ruhwald M, Rüssmann H, Marx FM, Wahn U, Magdorf K. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study. Scand J Infect Dis. 2012;44(4):256-262
17. Yassin MA, Petrucci R, Garie KT, et al. Can interferon-gamma or interferon-gamma-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas? PLoS One. 2011;6(9):e23733
18. Whittaker E, Gordon A, Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma? PLoS One. 2008;3(12):e3901
19. Syed Ahamed Kabeer B, Paramasivam P, Raja A. Interferon gamma and interferon gamma inducible protein-10 in detecting tuberculosis infection. J Infect. 2012;64(6):573-579
20. Armand M, Chhor V, de Lauzanne A, et al. Cytokine responses to quantiferon peptides in pediatric tuberculosis: a pilot study. J Infect. 2014;68(1):62-70
21. Goletti D, Raja A, Syed Ahamed Kabeer B, et al. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS One. 2010;5(9):e12577
22. Vanini V, Petruccioli E, Gioia C, et al. IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country. J Infect. 2012;65(1):49-59
23. Rose MV, Kimaro G, Nissen TN, et al. QuantiFERON®-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden setting. PLoS One. 2012;7(7):e37851
24. Graham SM, Ahmed T, Amanullah F, et al. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis. 2012;205(suppl 2):S199-S208
25. Aabye MG, Eugen-Olsen J, Werlinrud AM, et al. A simple method to quantitate IP-10 in dried blood and plasma spots. PLoS One. 2012;7(6):e39228
26. Bossuyt PM, Reitsma JB, Bruns DE, et al; Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Radiol. 2003;58(8):575-580
27. Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2011;15(8):1018-1032
28. Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, et al. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J. 2011;30(8):694-700
29. Okada K, Mao TE, Mori T, et al. Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children. Epidemiol Infect. 2008;136(9):1179-1187
30. Dogra S, Narang P, Mendiratta DK, et al. Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect. 2007;54(3):267-276
31. Banfield S, Pascoe E, Thambiran A, Siafarikas A, Burgner D. Factors associated with the performance of a blood-based interferon-γ release assay in diagnosing tuberculosis. PLoS One. 2012;7(6):e38556
32. Aabye MG, Ravn P, PrayGod G, et al. The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One. 2009;4(1):e4220
33. Thomas TA, Mondal D, Noor Z, et al. Malnutrition and helminth infection affect performance of an interferon γ-release assay. Pediatrics. 2010;126(6). Available at: www.pediatrics.org/cgi/content/full/126/6/e1522
34. Holm LL, Rose MV, Ravn P. Perspectives in implementing standardized case definitions for tuberculosis research involving children in a low-income, high-burden setting. J Infect Dis. 2013;207(5):870-871
35. Yassin MA, Petrucci R, Garie KT, et al. Use of tuberculin skin test, IFN-γ release assays and IFN-γ-induced protein-10 to identify children with TB infection. Eur Respir J. 2013;41(3):644-648
36. Ruhwald M, Petersen J, Kofoed K, et al. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One. 2008;3(8):e2858
37. Basu Roy R, Whittaker E, Kampmann B. Current understanding of the immune response to tuberculosis in children. Curr Opin Infect Dis. 2012;25(3):250-257
38. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-γ-based assay using new antigens. Am J Respir Crit Care Med. 2004; 170(1):59-64